OSI Pharmaceuticals (OSIP) - formerly Oncogene Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : OSI Pharmaceuticals (OSIP) - formerly Oncogene

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (186)	10/16/2002 9:15:45 AM
From: nigel bates	Read Replies (1) of 447

We do not know Iressa PIII tox profile for stage IIIb/IV NSCLC... Do we need to ? Re-reading the PR - This side-effect was known to AstraZeneca throughout* the drug's clinical development...* Surely this would imply that either ABGX or OSIP should have spotted a similar problem, by now ? nig

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next